Shelterin complex and associated factors at human telomeres

Nucleus

Volumn 2, Issue 2, 2011, Pages

  Diotti, Rafaella ^a   Loayza, Diego ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

Apollo; Shelterin; Tankyrase; Telomere; TRF1; TRF2

Indexed keywords

CHROMOSOME PROTEIN; DNA; RNA; SHELTERIN; TELOMERASE; TELOMERIC REPEAT BINDING FACTOR 1; TELOMERIC REPEAT BINDING FACTOR 2; UNCLASSIFIED DRUG;

CHROMOSOME; DNA DAMAGE; DNA REPLICATION; HUMAN; MOLECULAR DOCKING; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN STRUCTURE; REVIEW; TELOMERE;

EID: 79953324961     PISSN: 19491034     EISSN: 19491042     Source Type: Journal    
DOI: 10.4161/nucl.2.2.15135     Document Type: Review

References (155)

1. de Lange T. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 2005; 19:2100-10.
2. Blackburn EH. Switching and signaling at the telomere. Cell 2001; 106:661-73.
3. Hayflick L. How and why we age. Exp Gerontol 1998; 33:639-53.
4. Sedivy JM. Telomeres limit cancer growth by inducing senescence: long-sought in vivo evidence obtained. Cancer Cell 2007; 11:389-91.
5. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, et al. Extension of life-span by introduction of telomerase into normal human cells. Science 1998; 279:349-52.
6. Greider CW. Telomeres and senescence: the history, the experiment, the future. Curr Biol 1998; 8:178-81.
7. Lin SY, Elledge SJ. Multiple tumor suppressor pathways negatively regulate telomerase. Cell 2003; 113:881-9.
8. Smogorzewska A, de Lange T. Regulation of telomerase by telomeric proteins. Annu Rev Biochem 2004; 73:177-208.
9. Verdun RE, Karlseder J. The DNA damage machinery and homologous recombination pathway act consecutively to protect human telomeres. Cell 2006; 127:709-20.
10. Zhao Y, Sfeir AJ, Zou Y, Buseman CM, Chow TT, Shay JW, et al. Telomere extension occurs at most chromosome ends and is uncoupled from fill-in in human cancer cells. Cell 2009; 138:463-75.
11. Sfeir AJ, Chai W, Shay JW, Wright WE. Telomere-end processing the terminal nucleotides of human chromosomes. Mol Cell 2005; 18:131-8.
12. Verdun RE, Karlseder J. Replication and protection of telomeres. Nature 2007; 447:924-31.
13. Oganesian L, Karlseder J. Telomeric armor: the layers of end protection. J Cell Sci 2009; 122:4013-25.
14. Verdun RE, Crabbe L, Haggblom C, Karlseder J. Functional human telomeres are recognized as DNA damage in G of the cell cycle. Molecular Cell 2005; 20:551-61.
15. Hahn WC, Weinberg RA. Modelling the molecular circuitry of cancer. Nat Rev Cancer 2002; 2:331-41.
16. Kirwan M, Dokal I. Dyskeratosis congenita: a genetic disorder of many faces. Clin Genet 2008; 73:103-12.
17. Kirwan M, Dokal I. Dyskeratosis congenita, stem cells and telomeres. Biochim Biophys Acta 2009; 1792:371-9.
18. Touzot F, Callebaut I, Soulier J, Gaillard L, Azerrad C, Durandy A, et al. Function of Apollo (SNM1B) at telomere highlighted by a splice variant identified in a patient with Hoyeraal-Hreidarsson syndrome. Proc Natl Acad Sci 2010; 107:10097-102.
19. Hockemeyer D, Palm W, Wang RC, Couto SS, de Lange T. Engineered telomere degradation models dyskeratosis congenita. Genes Dev 2008; 22:1773-85.
20. Baumann P, Cech TR. Pot1, the putative telomere end-binding protein in fission yeast and humans. Science 2001; 292:1171-5.
21. Loayza D, de Lange T. POT1 as a terminal transducer of TRF1 telomere length control. Nature 2003; 424:1013-8.
22. Broccoli D, Smogorzewska A, Chong L, de Lange T Human telomeres contain two distinct Myb-related proteins, TRF1 and TRF2. Nat Genet 1997; 17:231-5.
23. Zhong Z, Shiue L, Kaplan S, de Lange T. A mammalian factor that binds telomeric TTA GGG repeats in vitro. Mol Cell Biol 1992; 12:4834-43.
24. van Steensel B, de Lange T. Control of telomere length by the human telomeric protein TRF1. Nature 1997; 385:740-3.
25. Takai KK, Hooper SM, Blackwood SL, Gandhi R, de Lange T. In vivo stoichiometry of shelterin components. J Biol Chem 2009; 22:1773-85.
26. Palm W, de Lange T. How shelterin protects mammalian telomeres. Annu Rev Genet 2008; 42:301-34.
27. Liu D, O'Connor MS, Qin J, Songyang Z. Telosome, a mammalian telomere-associated complex formed by multiple telomeric proteins. J Biol Chem 2004; 279:51338-42.
28. Celli GB, de Lange T. DNA processing is not required for ATM-mediated telomere damage response after TRF2 deletion. Nat Cell Biol 2005; 7:712-8.
29. Lazzerini Denchi E, de Lange T. Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1. Nature 2007; 448:1068-71.
30. Takai H, Smogorzewska A, de Lange T. DNA damage foci at dysfunctional telomeres. Curr Biol 2003; 13:1549-56.
31. d'Adda di Fagagna F, Reaper PM, Clay-Farrace L, Fiegler H, Carr P, Von Zglinicki T, et al. A DNA damage checkpoint response in telomere-initiated senescence. Nature 2003; 426:194-8.
32. Smith S, Giriat I, Schmitt A, de Lange T Tankyrase, a poly(ADP-ribose) polymerase at human telomeres. Science 1998; 282:1484-7.
33. Lee TH, Perrem K, Harper JW, Lu KP, Zhou XZ. The F-box protein FBX4 targets PIN2/TRF1 for ubiquitin-mediated degradation and regulates telomere maintenance. J Biol Chem 2006; 281:759-68.
34. Durkin SG, Glover TW. Chromosome fragile sites. Annu Rev Genet 2007; 41:169-92.
35. Sfeir A, Kosiyatrakul ST, Hockemeyer D, MacRae SL, Karlseder J, Schildkraut CL, et al. Mammalian telomeres resemble fragile sites and require TRF1 for efficient replication. Cell 2009; 138:90-103.
36. Schoeftner S, Blasco MA. Developmentally regulated transcription of mammalian telomeres by DNA-dependent RNA polymerase II. Nat Cell Biol 2008; 10:228-36.
37. Azzalin CM, Reichenbach P, Khoriauli L, Giulotto E, Lingner J. Telomeric repeat containing RNA and RNA surveillance factors at mammalian chromosome ends. Science 2007; 318:798-801.
38. Feuerhahn S, Iglesias N, Panza A, Porro A, Lingner J. TERRA biogenesis, turnover and implications for function. FEBS Lett 2010; 584:3812-8.
39. Nergadze SG, Farnung BO, Wischnewski H, Khoriauli L, Vitelli V, Chawla R, et al. CpG-island promoters drive transcription of human telomeres. RNA 2009; 15:2186-94.
40. Horard B, Gilson E. Telomeric RNA enters the game. Nat Cell Biol 2008; 10:113-5.
41. Redon S, Reichenbach P, Lingner J. The non-coding RNA TERRA is a natural ligand and direct inhibitor of human telomerase. Nucleic Acids Res 2010; 38:5797-806.
42. Deng Z, Norseen J, Wiedmer A, Riethman H, Lieberman PM. TERRA RNA binding to TRF2 facilitates heterochromatin formation and ORC recruitment at telomeres. Mol Cell 2009; 35:403-13.
43. Wang RC, Smogorzewska A, de Lange T Homologous recombination generates T-loop-sized deletions at human telomeres. Cell 2004; 119:355-68.
44. Deng Y, Guo X, Ferguson DO, Chang S. Multiple roles for MRE11 at uncapped telomeres. Nature 2009; 460:914-8.
45. Wu Y, Xiao S, Zhu XD. MRE11-RAD50-NBS1 and ATM function as co-mediators of TRF1 in telomere length control. Nat Struct Mol Biol 2007; 14:832-40.
46. Zhu XD, Kuster B, Mann M, Petrini JH, de Lange T. Cell cycle-regulated association of RAD50/MRE11/ NBS1 with TRF2 and human telomeres. Nat Genet 2000; 25:347-52.
47. Wu P, van Overbeek M, Rooney S, de Lange T. Apollo contributes to G overhang maintenance and protects leading-end telomeres. Mol Cell 2010; 39:606-17.
48. Lenain C, Bauwens S, Amiard S, Brunori M, Giraud-Panis MJ, Gilson E. The Apollo 5' exonuclease functions together with TRF2 to protect telomeres from DNA repair. Curr Biol 2006; 16:1303-10.
49. van Overbeek M, de Lange T. Apollo, an Artemis-related nuclease, interacts with TRF2 and protects human telomeres in S phase. Curr Biol 2006; 16:1295-302.
50. Dejardin J, Kingston RE. Purification of proteins associated with specific genomic Loci. Cell 2009; 136:175-86.
51. Giannone RJ, McDonald HW, Hurst GB, Shen RF, Wang Y, Liu Y The protein network surrounding the human telomere repeat binding factors TRF1, TRF2 and POT1. PLoS One 2010; 5:12407.
52. Nittis T, Guittat L, LeDuc RD, Dao B, Duxin JP, Rohrs H, et al. Revealing novel telomere proteins using in vivo cross-linking, tandem affinity purification and label-free quantitative LC-FTICR-MS. Mol Cell Proteomics 2010; 9:1144-56.
53. Lee OH, Kim H, He Q, Baek HJ, Yang D, Chen LY, et al. Genome-wide YFP fluorescence complementation screen identifies new regulators for telomere signaling in human cells. Mol Cell Proteomics 2010; [Epub ahead of print].
54. Chen Y, Yang Y, van Overbeek M, Donigian JR, Baciu P, de Lange T, Lei M. A shared docking motif in TRF1 and TRF2 used for differential recruitment of telomeric proteins. Science 2008; 319:1092-6.
55. Bianchi A, Smith S, Chong L, Elias P, de Lange T. TRF1 is a dimer and bends telomeric DNA. EMBO J 1997; 16:1785-94.
56. Fairall L, Chapman L, Moss H, de Lange T, Rhodes D. Structure of the TRFH dimerization domain of the human telomeric proteins TRF1 and TRF2. Molecular Cell 2001; 8:351-61.
57. Kim H, Lee OH, Xin H, Chen LY, Qin J, Chae HK, et al. TRF2 functions as a protein hub and regulates telomere maintenance by recognizing specific peptide motifs. Nat Struct Mol Biol 2009; 16:372-9.
58. Sbodio JI, Chi NW. Identification of a tankyrase-binding motif shared by IRAP, TAB182 and human TRF1 but not mouse TRF1. NuMA contains this RXXPDG motif and is a novel tankyrase partner. J Biol Chem 2002; 277:31887-92.
59. Smith S. The world according to PARP Trends. Biochem Sci 2001; 26:174-9.
60. Hsiao SJ, Smith S. Tankyrase function at telomeres, spindle poles and beyond. Biochimie 2008; 90:83-92.
61. Smith S, de Lange T. Tankyrase promotes telomere elongation in human cells. Curr Biol 2000; 10:1299-302.
62. Donigian JR, de Lange T. The role of the poly(ADP-ribose) polymerase tankyrase1 in telomere length control by the TRF1 component of the shelterin complex. J Biol Chem 2007; 282:22662-7.
63. Dynek JN, Smith S. Resolution of sister telomere association is required for progression through mitosis. Science 2004; 304:97-100.
64. Canudas S, Houghtaling BR, Kim JY, Dynek JN, Chang WG, Smith S. Protein requirements for sister telomere association in human cells. EMBO 2007; 26:4867-78.
65. Canudas S, Smith S. Differential regulation of telomere and centromere cohesion by the Scc3 homologues SA1 and SA2, respectively, in human cells. J Cell Biol 2009; 187:165-73.
66. Hsiao SJ, Smith S. Sister telomeres rendered dysfunctional by persistent cohesion are fused by NHEJ. J Cell Biol 2009; 184:515-26.
67. Dregalla RC, Zhou J, Idate RR, Battaglia CL, Liber HL, Bailey SM. Regulatory roles of tankyrase 1 at telomeres and in DNA repair: suppression of T-SCE and stabilization of DNA-PKcs. Aging 2010; 2:691-708.
68. Chang S. The telomere protein tankyrase 1 regulates DNA damage responses at telomeres. Aging 2010; 2:639-42.
69. Cook BD, Dynek JN, Chang W, Shostak G, Smith S. Role for the related poly (ADP-Ribose) polymerases tankyrase 1 and 2 at human telomeres. Mol Cell Biol 2002; 22:332.
70. Zhou XZ, Lu KP. The Pin2/TRF1-interacting protein PinX1 is a potent telomerase inhibitor. Cell 2001; 107:347-59.
71. Soohoo CY, Shi R, Lee TH, Huang P, Lu KP, Zhou XZ. Telomerase inhibitor PINX1 provides a link between TRF1 and telomerase to prevent telomere elongation. J Biol Chem 2010; 286:3894-906.
72. Chang W, Dynek JN, Smith S. TRF1 is degraded by ubiquitin-mediated proteolysis after release from telomeres. Genes Dev 2003; 17:1328-33.
73. Lee TH, Tun-Kyi A, Shi R, Lim J, Soohoo C, Finn G, et al. Essential role of Pin1 in the regulation of TRF1 stability and telomere maintenance. Nat Cell Biol 2009; 11:97-105.
74. Zhu Q, Meng L, Hsu JK, Lin T, Teishima J, Tsai RY. GNL3L stabilizes the TRF1 complex and promotes mitotic transition. J Cell Biol 2009; 185:827-39.
75. Zhu Q, Yasumoto H, Tsai RY. Nucleostemin delays cellular senescence and negatively regulates TRF1 protein stability. Mol Cell Biol 2006; 26:9279-90.
76. Rooney S, Sekiguchi J, Zhu C, Cheng HL, Manis J, Whitlow S, et al. Leaky Scid phenotype associated with defective V(D)J coding end processing in Artemis-deficient mice. Mol Cell 2002; 10:1379-90.
77. Bae JB, Mukhopadhyay SS, Liu L, Zhang N, Tan J, Akhter S, et al. Snm1B/Apollo mediates replication fork collapse and S Phase checkpoint activation in response to DNA interstrand cross links. Oncogene 2008; 27:5045-56.
78. Ye J, Lenain C, Bauwens S, Rizzo A, Saint-Leger A, Poulet A, et al. TRF2 and apollo cooperate with topoisomerase 2alpha to protect human telomeres from replicative damage. Cell 2010; 142:230-42.
79. Lam YC, Akhter S, Gu P, Ye J, Poulet A, Giraud-Panis MJ, et al. SNMIB/Apollo protects leading-strand telomeres against NHEJ-mediated repair. EMBO 2010; 29:2230-41.
80. Sarthy JF, Baumann P. Apollo-taking the lead in telomere protection. Mol Cell 2010; 39:489-91.
81. Dimitrova N, de Lange T. Cell cycle-dependent role of MRN at dysfunctional telomeres: ATM signaling-dependent induction of nonhomologous end joining (NHEJ) in G and resection-mediated inhibition of NHEJ in G. Mol Cell Biol 2009; 29:5552-63.
82. Attwooll CL, Akpinar M, Petrini JH. The Mre11 complex and the response to dysfunctional telomeres. Mol Cell Biol 2009; 29:5540-51.
83. Lee JH, Paull TT. Activation and regulation of ATM kinase activity in response to DNA double-strand breaks. Oncogene 2007; 26:7741-8.
84. Chai W, Sfeir AJ, Hoshiyama H, Shay JW, Wright WE. The involvement of the Mre11/Rad50/Nbs1 complex in the generation of G-overhangs at human telomeres. EMBO Rep 2006; 7:225-30.
85. Landsverk HB, Mora-Bermudez F, Landsverk OJ, Hasvold G, Naderi S, Bakke O, et al. The protein phosphatase 1 regulator PNUTS is a new component of the DNA damage response. EMBO Rep 2010; 11:868-75.
86. Mohammad DH, Yaffe MB. 14-3-3 proteins, FHA domains and BRCT domains in the DNA damage response. DNA Repair 2009; 8:1009-17.
87. Xu X, Lee J, Stern DF. Microcephalin is a DNA damage response protein involved in regulation of CHK1 and BRCA1. J Biol Chem 2004; 279:34091-4.
88. Gavvovidis I, Pöhlmann, C, Marchal JA, Stumm M, Yamashita D, Hirano T, et al. MCPH1 patient cells exhibit delayed release from DNA damage-induced G /M checkpoint arrest. Cell Cycle 2010; 9:4893-9.
89. Lin SY, Liang Y, Li K Multiple roles of BRIT1/ MCPH1 in DNA damage response, DNA repair and cancer suppression. Yonsei Med J 2010; 51:295-301.
90. Kipling D, Faragher RG. Progeroid syndromes: probing the molecular basis of aging? Mol Pathol 1997; 50:234-41.
91. Schulz VP, Zakian VA, Ogburn CE, McKay J, Jarzebowicz AA, Edland SD, et al. Accelerated loss of telomeric repeats may not explain accelerated replicative decline of Werner syndrome cells. Hum Genet 1996; 97:750-4.
92. Hickson ID. RecQ helicases: caretakers of the genome. Nat Rev Cancer 2003; 3:169-78.
93. Ozgenc A, Loeb LA. Current advances in unraveling the function of the Werner syndrome protein. Mutat Res 2005; 577:237-51.
94. Dunham MA, Neumann AA, Fasching CL, Reddel RR. Telomere maintenance by recombination in human cells. Nat Genet 2000; 26:447-50.
95. Cesare AJ, Griffith JD. Telomeric DNA in ALT cells is characterized by free telomeric circles and heterogeneous t-loops. Mol Cell Biol 2004; 24:9948-57.
96. Opresko PL, Von Kobbe C, Laine JP, Harrigan J, Hickson ID, Bohr VA. Telomere binding protein TRF2 binds to and stimulates the Werner and Bloom syndrome helicases. J Biol Chem 2002; 277:41110-9.
97. Machwe A, Xiao L, Orren DK TRF2 recruits the Werner syndrome (WRN) exonuclease for processing of telomeric DNA. Oncogene 2004; 23:149-56.
98. Opresko PL, Mason PA, Podell ER, Lei M, Hickson ID, Cech TR, et al. POT1 stimulates RecQ helicases WRN and BLM to unwind telomeric DNA substrates. J Biol Chem 2005; 280:32069-80.
99. Crabbe L, Verdun RE, Haggblom CI, Karlseder J. Defective telomere lagging strand synthesis in cells lacking WRN helicase activity. Science 2004; 306:1951-3.
100. Li B, Jog SP, Reddy S, Comai L. WRN controls formation of extrachromosomal telomeric circles and is required for TRF2DeltaB-mediated telomere shortening. Mol Cell Biol 2008; 28:1892-904.
101. Sowd G, Lei M, Opresko PL. Mechanism and substrate specificity of telomeric protein POT1 stimulation of the Werner syndrome helicase. Nucleic Acids Res 2008; 36:4242-56.
102. Laud PR, Multani AS, Bailey SM, Wu L, Ma J, Kingsley C, et al. Elevated telomere-telomere recombination in WRN-deficient, telomere dysfunctional cells promotes escape from senescence and engagement of the ALT pathway. Genes Dev 2005; 19:2560-70.
103. Wyllie FS, Jones CJ, Skinner JW, Haughton MF, Wallis C, Wynford-Thomas D, et al. Telomerase prevents the accelerated cell ageing of Werner syndrome fibroblasts. Nat Genet 2000; 24:16-7.
104. Saharia A, Guittat L, Crocker S, Lim A, Steffen M, Kulkarni S, et al. Flap endonuclease 1 contributes to telomere stability. Curr Biol 2008; 18:496-500.
105. Saharia A, Teasley DC, Duxin JP, Dao B, Chiappinelli KB, Stewart SA. FEN1 ensures telomere stability by facilitating replication fork re-initiation. J Biol Chem 2010; 285:27057-66.
106. Deng Z, Lezina L, Chen CJ, Shtivelband S, So W, Lieberman PM. Telomeric proteins regulate episomal maintenance of Epstein-Barr virus origin of plasmid replication. Mol Cell 2002; 9:493-503.
107. Deng Z, Atanasiu C, Burg JS, Broccoli D, Lieberman PM. Telomere repeat binding factors TRF1, TRF2 and hRAP1 modulate replication of Epstein-Barr virus. OriP J Virol 2003; 77:11992-2001.
108. Atanasiu C, Deng Z, Wiedmer A, Norseen J, Lieberman PM. ORC binding to TRF2 stimulates OriP replication. EMBO Rep 2006; 7:716-21.
109. Deng Z, Dheekollu J, Broccoli D, Dutta A, Lieberman PM. The origin recognition complex localizes to telomere repeats and prevents telomere-circle formation. Curr Biol 2007; 17:1989-95.
110. Diffley JF, Labib K. The chromosome replication cycle. J Cell Sci 2002; 115:869-72.
111. Tatsumi Y, Ezura K, Yoshida K, Yugawa T, Narisawa-Saito M, Kiyono T, et al. Involvement of human ORC and TRF2 in pre-replication complex assembly at telomeres. Genes Cells 2008; 13:1045-59.
112. Ciccia A, Elledge SJ. The DNA damage response: making it safe to play with knives. Mol Cell 2010; 40:179-204.
113. Hoeijmakers JH. Genome maintenance mechanisms for preventing cancer. Nature 2001; 411:366-74.
114. Niedernhofer LJ, Garinis GA, Raams A, Lalai AS, Robinson AR, Appeldoorn E, et al. A new progeroid syndrome reveals that genotoxic stress suppresses the somatotroph axis. Nature 2006; 444:1038-43.
115. Zhu XD, Niedernhofer L, Kuster B, Mann M, Hoeijmakers JH, de Lange T. ERCC1/XPF removes the 3' overhang from uncapped telomeres and represses formation of telomeric DNA-containing double minute chromosomes. Mol Cell 2003; 12:1489-98.
116. Munoz P, Blanco R, Flores JM, Blasco MA. XPF nuclease-dependent telomere loss and increased DNA damage in mice overexpressing TRF2 result in premature aging and cancer. Nat Genet 2005; 37:1063-71.
117. Wu Y, Mitchell TR, Zhu XD. Human XPF controls TRF2 and telomere length maintenance through distinctive mechanisms. Mech Ageing Dev 2008; 129:602-10.
118. Wu Y, Zacal NJ, Rainbow AJ, Zhu XD. XPF with mutations in its conserved nuclease domain is defective in DNA repair but functions in TRF2-mediated telomere shortening. DNA Repair 2007; 6:157-66.
119. Derheimer FA, Kastan MB. Multiple roles of ATM in monitoring and maintaining DNA integrity. FEBS Lett 2010; 584:3675-81.
120. Herbig U, Jobling WA, Chen BP, Chen DJ, Sedivy JM. Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53 and p21(CIP1), but not p16(INK4a). Mol Cell 2004; 14:501-13.
121. Bakkenist CJ, Kastan MB. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 2003; 421:499-506.
122. Karlseder J, Broccoli D, Dai Y, Hardy S, de Lange T. p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science 1999; 283:1321-5.
123. Karlseder J, Hoke K, Mirzoeva OK, Bakkenist C, Kastan MB, Petrini JH, et al. The telomeric protein TRF2 binds the ATM kinase and can inhibit the ATM-dependent DNA damage response. PLoS Biol 2004; 2:240.
124. Buscemi G, Zannini L, Fontanella E, Lecis D, Lisanti S, Delia D. The shelterin protein TRF2 inhibits Chk2 activity at telomeres in the absence of DNA damage. Curr Biol 2009; 19:874-9.
125. Ahn JY, Schwarz JK, Piwnica-Worms H, Canman CE. Threonine 68 phosphorylation by ataxia telangiectasia mutated is required for efficient activation of Chk2 in response to ionizing radiation. Cancer Res 2000; 60:5934-6.
126. Kishi S, Zhou XZ, Ziv Y, Khoo C, Hill DE, Shiloh Y, Lu KP Telomeric protein Pin2/TRF1 as an important ATM target in response to double strand DNA breaks. J Biol Chem 2001; 276:29282-91.
127. Burrows AE, Elledge SJ. How ATR turns on: TopBP1 goes on ATRIP with ATR. Genes Dev 2008; 22:1416-21.
128. Gong Y, de Lange T. A Shld1-controlled POT1a provides support for repression of ATR signaling at telomeres through RPA exclusion. Molecular Cell 2010; 40:377-87.
129. Kibe T, Osawa GA, Keegan CE, de Lange T. Telomere protection by TPP1 is mediated by POT1a and POT1b. Mol Cell Biol 2010; 30:1059-66.
130. Konishi A, de Lange T. Cell cycle control of telomere protection and NHEJ revealed by ats mutation in the DNA-binding domain of TRF2. Genes Dev 2008; 22:1221-30.
131. Bianchi A, de Lange T. Ku binds telomeric DNA in vitro. J Biol Chem 1999; 274:21223-7.
132. Hsu HL, Gilley D, Blackburn EH, Chen DJ. Ku is associated with the telomere in mammals. Proc Natl Acad Sci 1999; 96:12454-8.
133. d'Adda di Fagagna F, Hande MP, Tong WM, Roth D, Lansdorp PM, Wang ZQ, et al. Effects of DNA nonhomologous end-joining factors on telomere length and chromosomal stability in mammalian cells. Curr Biol 2001; 11:1192-6.
134. Hsu HL, Gilley D, Galande SA, Hande MP, Allen B, Kim SH, et al. Ku acts in a unique way at the mammalian telomere to prevent end joining. Genes Dev 2000; 14:2807-12.
135. Song K, Jung D, Jung Y, Lee SG, Lee I. Interaction of human Ku70 with TRF2. FEBS Lett 2000; 481:81-5.
136. Myung K, Ghosh G, Fattah FJ, Li G, Kim H, Dutia A, et al. Regulation of telomere length and suppression of genomic instability in human somatic cells by Ku86. Mol Cell Biol 2004; 24:5050-9.
137. Wang Y, Ghosh G, Hendrickson EA. Ku86 represses lethal telomere deletion events in human somatic cells. Proc Natl Acad Sci 2009; 106:12430-5.
138. Celli GB, Denchi EL, de Lange T Ku70 stimulates fusion of dysfunctional telomeres yet protects chromosome ends from homologous recombination. Nat Cell Biol 2006; 8:885-90.
139. Sfeir A, Kabir S, van Overbeek M, Celli GB, de Lange T. Loss of Rap1 induces telomere recombination in the absence of NHEJ or a DNA damage signal. Science 2010; 327:1657-61.
140. Sheppard SA, Loayza D. LIM-domain proteins TRIP6 and LPP associate with shelterin to mediate telomere protection. Aging 2010; 2:432-44.
141. Kadrmas JL, Beckerle MC. The LIM domain: from the cytoskeleton to the nucleus. Nat Rev Mol Cell Biol 2004; 5:920-31.
142. Yi J, MC B. The human TRIP6 gene encodes a LIM domain protein and maps to chromosome 7q22, a region associated with tumorigenesis. Genomics 1998; 49:314-6.
143. Hou Z, Peng H, White DE, Negorev DG, Maul GG, Feng Y, et al. LIM protein Ajuba functions as a nuclear receptor corepressor and negatively regulates retinoic acid signaling. Proc Natl Acad Sci 2010; 107:2938-43.
144. Mitchell TR, Glenfield K, Jeyanthan K, Zhu XD. Arginine methylation regulates telomere length and stability. Mol Cell Biol 2009; 29:4918-34.
145. Price CM, Boltz KA, Chaiken MF, Stewart JA, Beilstein MA, Shippen DE. Evolution of CST function in telomere maintenance. Cell Cycle 2010; 9:3157-65.
146. Giraud-Panis MJ, Teixeira MT, Géli V, Gilson E. CST meets shelterin to keep telomeres in check. Mol Cell 2010; 39:665-76.
147. Miyake Y, Nakamura M, Nabetani A, Shimamura S, Tamura M, Yonehara S, et al. RPA-like mammalian Ctc1-Stn1-Ten1 complex binds to single-stranded DNA and protects telomeres independently of the Pot1 pathway. Mol Cell 2009; 36:193-206.
148. Ye JZ, Donigian JR, Van Overbeek M, Loayza D, Luo Y, Krutchinsky AN, et al. TIN2 binds TRF1 and TRF2 simultaneously and stabilizes the TRF2 complex on telomeres. J Biol Chem 2004; 279:47264-71.
149. Lei M, Podell ER, Cech TR. Structure of human POT1 bound to telomeric single-stranded DNA provides a model for chromosome end-protection. Nat Struct Mol Biol 2004; 11:1223-9.
150. Li B, Oestreich S, de Lange T. Identification of human Rap1: implications for telomere evolution. Cell 2000; 101:471-83.
151. Bianchi A, Stansel RM, Fairall L, Griffith JD, Rhodes D, de Lange T TRF1 binds a bipartite telomeric site with extreme spatial flexibility. EMBO J 1999; 18:5735-44.
152. Hanaoka S, Nagadoi A, Nishimura Y Comparison between TRF2 and TRF1 of their telomeric DNA-bound structures and DNA-binding activities. Protein Sci 2005; 14:119-30.
153. Kishi S, Lu KP. A critical role for Pin2/TRF1 in ATM-dependent regulation: Inhibition of Pin2/TRF1 function complements telomere shortening, the radio-sensitivity and G /M checkpoint defect of Ataxia-Telangiectasia cells. J Biol Chem 2001; 277:7420-9.
154. Tarsounas M, West SC. Recombination at mammalian telomeres: an alternative mechanism for telomere protection and elongation. Cell Cycle 2005; 4:672-4.
155. Uringa EJ, Youds JL, Lisaingo K, Lansdorp PM, Boulton SJ. RTEL1: an essential helicase for telomere maintenance and the regulation of homologous recombination. Nucleic Acids Res 2010; doi: 10.1093/nar/ gkq1045.